Hyperspectral microscopy imaging to analyze pathology samples with multicolors reduces time and cost

By taking advantage of the continuous spectrum collected for each image pixel by the Hyperspectral Microscopy Imaging (HMI) system, the data spectra can be de-convolved into a set of standard spectra coefficients for each pixel. The coefficients are calculated by the analysis program and indicate the relative amounts of each standard necessary to reproduce the data spectra for each image pixel. Images of a single color or composite images of two or more colors can be produced for visual analysis. The HMI system is composed of an Olympus inverted microscope, imaging spectrograph, CCD camera, motorized X-Y stage and illumination sources. This system has been used to scan and analyze pathology tissue samples which have been stained with 4 standard fluorochromes (not including the dynamic background spectrum) attached to specific antibodies. The typical wavelength range is 420nm to 785nm with the longest wavelength markers emitting in the spectral region where the human eye is not sensitive. Quantitative values are recorded and can be compared to the visual interpretations.

[1]  D. Hayes,et al.  Comparison of HER-2 Overexpression in Primary Breast Cancer and Metastatic Sites and Its Effect on Biological Targeting Therapy of Metastatic Disease , 2006 .

[2]  P. Tan,et al.  Prognostic Significance of Glutathione S-Transferase-Pi in Invasive Breast Cancer , 2003, Modern Pathology.

[3]  Jerilyn A. Timlin,et al.  Advanced imaging of multiple mRNAs in brain tissue using a custom hyperspectral imager and multivariate curve resolution , 2006, Journal of Neuroscience Methods.

[4]  M.L. Huebschman,et al.  Characteristics and capabilities of the hyperspectral imaging microscope , 2002, IEEE Engineering in Medicine and Biology Magazine.

[5]  Tanja Fehm,et al.  Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  Thomas D. Nielsen,et al.  Hyperspectral imaging: a novel approach for microscopic analysis. , 2001, Cytometry.

[7]  Robert D. Guenther,et al.  Encyclopedia of modern optics , 2005 .

[8]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[9]  Tanja Fehm,et al.  HER-2 gene amplification can be acquired as breast cancer progresses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Hisae Niki,et al.  A new immunofluorostaining method using red fluorescence of PerCP on formalin-fixed paraffin-embedded tissues. , 2004, Journal of immunological methods.

[11]  Cornelis J H van de Velde,et al.  Four‐color staining combining fluorescence and brightfield microscopy for simultaneous immune cell phenotyping and localization in tumor tissue sections , 2005, Microscopy research and technique.

[12]  W. Fraser Symmans,et al.  Standardizing Slide-Based Assays in Breast Cancer: Hormone Receptors, HER2, and Sentinel Lymph Nodes , 2007, Clinical Cancer Research.

[13]  K. Bloom,et al.  The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. , 2003, The oncologist.

[14]  J. Reis-Filho,et al.  Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue , 2008, BMC Cell Biology.

[15]  Sanjay Shete,et al.  uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues , 2006, Proceedings of the National Academy of Sciences.